Skip to content
NCRI logo alt test Toggle Menu

Main Navigation

  • About us
    • Overview
    • Our Partners
    • Our Team
    • Our Trustees
    • Our Strategy
    • Jobs and Opportunities
  • How We Work
    • NCRI Groups
    • NCRI Networks
    • Proposal Guidance
    • Clinical Trials Units
    • Patients and Carers
    • Early Career Researchers
    • Cancer Research Database
  • Areas of Interest
    • Cancer and Covid-19
    • Health Data and AI
    • Immunotherapy and Immunology
    • Living with and Beyond Cancer
    • Pathology Group
    • Prevention and Early Diagnosis
    • Radiotherapy
  • News and Events
    • News
    • Events
    • Reports and Publications
Newsletter sign up

Radiotherapy

Filter Posts By:

  • Areas of Interest
    • Cancer Research Funding
    • Clinical Research Delivery
    • COVID-19
    • Health Data and AI
    • Imaging
    • Immunotherapy & Immunology
    • Living With & Beyond Cancer
    • Pathology
    • Patient & Public Involvement
    • Prevention & Early Diagnosis
    • Radiotherapy
    • Training & Retention
  • Cancers
    • Bladder & Renal
    • Brain
    • Breast
    • Children
    • Colorectal
    • Gynaecological
    • Haematological
    • Head & Neck
    • Lung
    • Lymphoma
    • Prostate
    • Sarcoma
    • Skin
    • TYA
    • Upper Gastrointestinal
  • Content
    • Blog
    • Case Study
    • Interviews
    • News
    • Press Releases

Reset Filters

'

Gold nanoparticles help deliver lethal one-two punch to cancer

'
08 November 2016

Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a…

Read More

'

CTRad review of molecular radiotherapy research in the UK

'
01 June 2016

CTRad has published its review of molecular radiotherapy (MRT) research in the UK. MRT has considerable potential to benefit patients,…

Read More

'

Identifying opportunities to promote progress in molecular radiotherapy research in the UK

'
01 June 2016

NCRI’s Clinical and Translational Radiotherapy Research Working Group (CTRad) has published its review of molecular radiotherapy (MRT) research in the…

Read More

'

A triumph for collaboration in radiotherapy research: landmark paper published by NCRI CTRad

'
26 May 2016

An NCRI CTRad Working Group has published a landmark paper in Nature Reviews Clinical Oncology setting out consensus recommendations to…

Read More

'

Interview with Professor Anthony Chalmers, Chair of NCRI CTRad

'
13 April 2016

Professor Anthony Chalmers is Professor of Clinical Oncology at the University of Glasgow, honorary consultant at the Beatson West of…

Read More

'

Proton Beam Therapy: NCRI Consumer Forum members get the lowdown

'
18 September 2015

NCRI recently held an educational day for some of its Consumer Forum members on Proton Beam Therapy (PBT)  – a current hot…

Read More

'

CTRad: developing the latest radiotherapy trials

'
14 July 2015

CTRad organises Proposal Guidance Meetings up to twice a year, where investigators who have ideas for radiotherapy research are invited…

Read More

'

CTRad leadership and membership appointments 2015

'
05 June 2015

CTRad is pleased to announce that following the co-chairs application and interview process, from 1 June 2015 four of the…

Read More

'

Radiotherapy: update from CTRad

'
02 June 2015

Radiotherapy update from CTRad Now in its sixth year, and with a new block of funding agreed until 2018, our radiotherapy initiative,…

Read More

'

CTRad: national leadership in radiotherapy research – Achievements and vision report now available

'
30 October 2014

CTRad has been running since 2009, and has been an important collaborative force for accelerating progress in the field. The…

Read More

'

NCRI Clinical and Translational Radiotherapy Research Working Group: latest news bulletin now available

'
01 July 2014

NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad) news bulletin is now available. » NCRI CTRad news bulletin, June…

Read More

'

Radiotherapy cuts deaths from high risk prostate cancer

'
08 November 2010

MEN TREATED with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to…

Read More

Posts navigation

  • «
  • 1
  • 2
  • 3
  • 4
  • »

National Cancer Research Institute (NCRI)

2 Redman Place London E20 1JQ
T: +44 (0)20 3469 8798
E: info@ncri.org.uk

NCRI is a Charitable Incorporated Organisation (registered charity number: 1160609)

  • Terms and Conditions
  • Privacy Policy
  • Newsletter